Cargando…

Melanoma vaccines.

Detalles Bibliográficos
Formato:	Texto
Lenguaje:	English
Publicado:	1998
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1533163/ https://www.ncbi.nlm.nih.gov/pubmed/9841209

Ejemplares similares

An epigenetic vaccine model active in the prevention and treatment of melanoma
por: Khan, A Nazmul H, et al.
Publicado: (2007)

Intratumoral therapies and in-situ vaccination for melanoma
por: Huppert, Laura A., et al.
Publicado: (2022)

Melanoma stem cell vaccine induces effective tumor immunity against melanoma
por: Yin, Qiliang, et al.
Publicado: (2023)

Use of the melanoma vaccine in 38 dogs: The South African experience
por: McLean, Joanne L., et al.
Publicado: (2015)

A nano-enhanced vaccine for metastatic melanoma immunotherapy
por: Salotto, Katelyn E., et al.
Publicado: (2022)

Melanoma Cells Treated with GGTI and IFN-γ Allow Murine Vaccination and Enhance Cytotoxic Response against Human Melanoma Cells
por: Sarrabayrouse, Guillaume, et al.
Publicado: (2010)

Safety and immunologic correlates of Melanoma GVAX, a GM-CSF secreting allogeneic melanoma cell vaccine administered in the adjuvant setting
por: Lipson, Evan J, et al.
Publicado: (2015)

Ex Vivo Derived Primary Melanoma Cells: Implications for Immunotherapeutic Vaccines
por: Suriano, Robert, et al.
Publicado: (2013)

Cripto-1 vaccination elicits protective immunity against metastatic melanoma
por: Ligtenberg, M. A., et al.
Publicado: (2016)

Short-course neoadjuvant in situ vaccination for murine melanoma
por: Aiken, Taylor J, et al.
Publicado: (2022)

Necrosis of uveal melanoma post-COVID-19 vaccination
por: Wagle, Ajeet M., et al.
Publicado: (2022)

The Effect of Vector Silencing during Picornavirus Vaccination against Experimental Melanoma and Glioma
por: Malo, Courtney S., et al.
Publicado: (2016)

Tumour-derived extracellular vesicle based vaccines for melanoma treatment
por: Gonzalez-Melero, Lorena, et al.
Publicado: (2023)

Analysis of melanoma tumor antigens and immune subtypes for the development of mRNA vaccine
por: Ping, Haiqin, et al.
Publicado: (2022)

Immuno-metabolic dendritic cell vaccine signatures associate with overall survival in vaccinated melanoma patients
por: Adamik, Juraj, et al.
Publicado: (2023)

A novel cancer vaccine for melanoma based on an approved vaccine against measles, mumps, and rubella
por: Fusciello, Manlio, et al.
Publicado: (2022)

Effect of vaccination with N-glycolyl GM3/VSSP vaccine by subcutaneous injection in patients with advanced cutaneous melanoma
por: Osorio, Marta, et al.
Publicado: (2012)

Efficiency of Dendritic Cell Vaccination against B16 Melanoma Depends on the Immunization Route
por: Edele, Fanny, et al.
Publicado: (2014)

Prophylactic Dendritic Cell-Based Vaccines Efficiently Inhibit Metastases in Murine Metastatic Melanoma
por: Markov, Oleg V., et al.
Publicado: (2015)

Immunologic responses to xenogeneic tyrosinase DNA vaccine administered by electroporation in patients with malignant melanoma
por: Yuan, Jianda, et al.
Publicado: (2013)

Cellular immunity induced by a recombinant adenovirus- human dendritic cell vaccine for melanoma
por: Naveh, Hadas Prag, et al.
Publicado: (2013)

Lymphangiogenesis-inducing vaccines elicit potent and long-lasting T cell immunity against melanomas
por: Sasso, Maria Stella, et al.
Publicado: (2021)

Intranodal vaccination with mRNA-optimized dendritic cells in metastatic melanoma patients
por: Bol, Kalijn F, et al.
Publicado: (2015)

Chronic granulomatous reaction in patients receiving vaccine immunotherapy for metastatic melanoma
por: Aria, Alexander B., et al.
Publicado: (2017)

Antitumor Properties of Epitope-Specific Engineered Vaccine in Murine Model of Melanoma
por: Stoyanova, Emiliya, et al.
Publicado: (2022)

Antibody response to melanoma helper-peptide vaccine correlates with survival
por: Olson, Walter C, et al.
Publicado: (2013)

Biohybrid Vaccines for Improved Treatment of Aggressive Melanoma with Checkpoint Inhibitor
por: Fontana, Flavia, et al.
Publicado: (2019)

Therapeutic cancer vaccination against telomerase: clinical developments in melanoma
por: Ellingsen, Espen Basmo, et al.
Publicado: (2023)

Safety and immunogenicity of a potential checkpoint blockade vaccine for canine melanoma
por: Kurupati, Raj K., et al.
Publicado: (2018)

Mucin 1 downregulation decreases the anti-tumor effects of melanoma vaccine
por: Shi, Fangfang, et al.
Publicado: (2022)

Combined vaccination and immunostimulatory antibodies provides durable cure of murine melanoma and induces transcriptional changes associated with positive outcome in human melanoma patients
por: McGray, A.J. Robert, et al.
Publicado: (2012)

Antitumour responses induced by a cell-based Reovirus vaccine in murine lung and melanoma models
por: Campion, Ciorsdan A., et al.
Publicado: (2016)

Multiple antigen-engineered DC vaccines with or without IFNα to promote antitumor immunity in melanoma
por: Butterfield, Lisa H., et al.
Publicado: (2019)

Ipilimumab administered to metastatic melanoma patients who progressed after dendritic cell vaccination
por: Boudewijns, Steve, et al.
Publicado: (2016)

Nano-delivery of fraxinellone remodels tumor microenvironment and facilitates therapeutic vaccination in desmoplastic melanoma
por: Hou, Lin, et al.
Publicado: (2018)

Checkpoint blockade inhibitors enhances the effectiveness of a Listeria monocytogenes-based melanoma vaccine
por: Gilley, Ryan P., et al.
Publicado: (2020)

Effectiveness of a Simply Designed Tumor Vaccine in Prevention of Malignant Melanoma Development
por: Novakovic, Srdjan, et al.
Publicado: (1999)

Effective pressure and treatment duration of high hydrostatic pressure to prepare melanoma vaccines
por: Liu, Kai, et al.
Publicado: (2020)

Improved overall survival in dendritic cell vaccination-induced immunoreactive subgroup of advanced melanoma patients
por: Ridolfi, Ruggero, et al.
Publicado: (2006)

Adjuvant dendritic cell vaccination in high-risk uveal melanoma patients
por: Bol, Kalijn, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_g4peu95k5sdc95di7njva2kjrr